首页> 外文期刊>Diabetes, metabolic syndrome and obesity: targets and therapy >Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
【24h】

Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy

机译:儿童肥胖,胰岛素抵抗和2型糖尿病的治疗:共识和争议

获取原文
           

摘要

Abstract: Childhood obesity has become a national and international epidemic. The prevalence and incidence of type 2 diabetes in youth have been increasing, and type 2 diabetes is one of the most challenging complications of obesity in childhood. Comprehensive lifestyle interventions that include attention to dietary change, increased physical activity and behavior change appear to be required for the successful treatment of pediatric obesity. In particular, aspects of behavioral interventions that have been identified as contributing to effectiveness have included intensity, parent/family participation, addressing healthy dietary change, promoting physical activity, and involving behavioral management principles such as goal setting. A multidisciplinary team approach is required for successful management of type 2 diabetes in youth as well. As with many therapies in pediatrics, clinical trials and support for treatments of obesity and type 2 diabetes in youth lag behind adult data. Pediatric recommendations may be extrapolated from adult data and are often based on consensus guidelines. Type 2 diabetes in children is most commonly managed with lifestyle modification and medications, metformin and/or insulin, the only medications currently approved for use in children. However, many opportunities exist for ongoing research to clarify optimal management for obesity and type 2 diabetes in youth.
机译:【摘要】儿童肥胖已成为一种流行病。青年人2型糖尿病的患病率和发病率一直在上升,2型糖尿病是儿童肥胖症最具挑战性的并发症之一。成功治疗小儿肥胖似乎需要全面的生活方式干预,包括注意饮食变化,增加体育锻炼和行为改变。尤其是,已被确认有助于提高有效性的行为干预措施包括强度,父母/家庭参与,解决健康的饮食变化,促进体育锻炼以及涉及行为管理原则(例如目标设定)。成功地管理青年2型糖尿病也需要多学科的团队方法。与儿科的许多疗法一样,青年时期的肥胖症和2型糖尿病的临床试验和支持落后于成人数据。儿科建议可以从成人数据中推断出来,并且通常基于共识性指导原则。儿童中的2型糖尿病最常见的方法是改变生活方式和药物,二甲双胍和/或胰岛素,这是目前唯一批准用于儿童的药物。但是,正在进行的研究为澄清肥胖症和2型糖尿病的最佳治疗方法提供了许多机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号